Bedrosian Camille L

CIK 00013269694 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001326969

Recent Transactions

50 trades

Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (Right to Buy)
2026-03-05+143,985→ 143,985 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2026-03-05+95,990→ 265,285 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2026-03-02$14.58/sh−6,461→ 169,295 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-12-01$14.35/sh−6,580→ 175,756 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-09-30$14.58/sh−12,039→ 182,336 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2025-06-24+7,037→ 7,037 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Restricted Stock Units
2025-06-24+4,712→ 4,712 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Restricted Stock Units
2025-06-18−4,000→ 0 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2025-06-18+4,000→ 7,000 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-06-11+6,900→ 16,300 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2025-06-11+10,350→ 10,350 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-03-31$3.47/sh−12,425→ 194,375 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-03-06+68,420→ 206,800 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (Right to Buy)
2025-03-06+102,630→ 102,630 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-12-02$5.54/sh−5,421→ 138,380 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-09-30$3.20/sh−11,442→ 143,801 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2024-06-21+3,000→ 3,000 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Restricted Stock Units
2024-06-21−3,000→ 0 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2024-06-18+14,000→ 14,000 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Restricted Stock Units
2024-06-18+4,000→ 4,000 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2024-06-07+12,500→ 12,500 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-06-07+3,400→ 9,400 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (Right to Buy)
2024-04-16+120,000→ 120,000 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-04-16+96,910→ 155,243 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (Right to Buy)
2023-11-27+162,500→ 162,500 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-11-27+58,333→ 58,333 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Restricted Stock Units
2023-06-21+3,000→ 3,000 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2023-06-21+14,000→ 14,000 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-06-16+6,000→ 6,000 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2023-06-16+17,500→ 17,500 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-03-01$45.25/sh−3,881→ 46,720 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-03-01+2,663→ 50,601 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2022-06-17+17,500→ 17,500 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2022-06-08+20,000→ 20,000 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2022-03-01+24,900→ 24,900 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-03-01$66.62/sh−2,821→ 33,938 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-03-01+14,000→ 47,938 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-01-30$66.30/sh−1,657→ 36,759 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-10-14$81.14/sh−359→ 38,416 total
Exercise/Conversion
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2021-09-02−2,500→ 53,000 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-09-02$100.18/sh−2,500→ 38,775 total
Exercise/Conversion
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-09-02$55.00/sh+2,500→ 41,275 total
Exercise/Conversion
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2021-09-01−2,500→ 55,500 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-09-01$100.03/sh−2,500→ 38,775 total
Exercise/Conversion
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-09-01$55.00/sh+2,500→ 41,275 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2021-06-22+17,500→ 17,500 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2021-06-09+15,000→ 15,000 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-05-06$113.67/sh−364→ 38,775 total
Exercise/Conversion
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option
2021-04-15−5,000→ 58,000 total
Exercise/Conversion
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-04-15$55.00/sh+5,000→ 44,139 total

Companies

Recent Filings

Address

C/O AMYLYX PHARMACEUTICALS, INC. 55 CAMBRIDGE PARKWAY, SUITE 6W

CAMBRIDGE, MA, 02142

View on SEC.gov